Freeline Therapeutics Holdings plc — key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2022)

-$89.0M

Total Assets (FY2022)

$86.6M

Total Equity (FY2022)

$52.4M

Cash Flows from Operating Activities (FY2022)

-$78.2M

Source: Freeline Therapeutics Holdings plc 20-F filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.